Back to Results
First PageMeta Content
Cancer / Lung cancer / Clinical medicine / Health / Non-small-cell lung carcinoma / Large-cell lung carcinoma / Squamous cell carcinoma / Small-cell carcinoma / Sanofi / Epidemiology of cancer / Anaplastic lymphoma kinase / Combined small-cell lung carcinoma


ZAI Lab announces a global licensing agreement with Sanofi for a novel compound to potentially treat NSCLC ShanghaiZAI Lab Limited (ZAI Lab), an innovative biotech company based in China, announced today
Add to Reading List

Document Date: 2015-07-30 22:49:46


Open Document

File Size: 299,99 KB

Share Result on Facebook